The economic impact of pandemic influenza in the United States: priorities for intervention.

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Meltzer, M. I. ; Cox, N. J. ; Fukuda, K.
• Description:
  We estimated the possible effects of the next influenza pandemic in the United States and analyzed the economic impact of vaccine-based interventions. Using death rates, hospitalization data, and outpatient visits, we estimated 89,000 to 207,000 deaths; 314,000 to 734,000 hospitalizations; 18 to 42 million outpatient visits; and 20 to 47 million additional illnesses. Patients at high risk (15% of the population) would account for approximately 84% of all deaths. The estimated economic impact would be US$71.3 to $166.5 billion, excluding disruptions to commerce and society. At $21 per vaccinee, we project a net savings to society if persons in all age groups are vaccinated. At $62 per vaccinee and at gross attack rates of 25%, we project net losses if persons not at high risk for complications are vaccinated. Vaccinating 60% of the population would generate the highest economic returns but may not be possible within the time required for vaccine effectiveness, especially if two doses of vaccine are required.
• Subjects:
  Adolescent Adult Aged Ambulatory Care Child Child, Preschool Disease Outbreaks Health Priorities Hospitalization Humans Infant Infant, Newborn Influenza, Human Influenza Vaccines Middle Aged Monte Carlo Method Research Article Risk Factors

  More +
• Source:
  Emerg Infect Dis. 5(5):659-671.
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Location:
  North America
• Volume:
  5
• Issue:
  5
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha-512:b78730488944b90bb2608c3eb08151b93005d8c3d96acab4f8af380a0fb536ff1ba486dbabfd31967d4d489f8694b9ee7b3a27646e860da94c9a9416aefb5a60
• Download URL:
  https://stacks.cdc.gov/view/cdc/3265/cdc_3265_DS1.pdf
• File Type:
  [PDF - 197.80 KB ]